On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.
On today's podcast, US Congressman Gus Bilirakis joins host Wayne Bowden to discuss the importance of rare disease awareness and treatment.
What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast. Host...
"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...